NEW SELECTIVE REACTIONS FOR ANTI-TUMOR AGENT SYNTHESIS

Information

  • Research Project
  • 3288619
  • ApplicationId
    3288619
  • Core Project Number
    R01GM035652
  • Full Project Number
    5R01GM035652-03
  • Serial Number
    35652
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/5/1985 - 39 years ago
  • Project End Date
    8/31/1988 - 36 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1987 - 37 years ago
  • Budget End Date
    8/31/1988 - 36 years ago
  • Fiscal Year
    1987
  • Support Year
    3
  • Suffix
  • Award Notice Date
    8/13/1987 - 37 years ago
Organizations

NEW SELECTIVE REACTIONS FOR ANTI-TUMOR AGENT SYNTHESIS

The long-term goals of this project are the discovery and development of new, selective synthetic reactions which can be applied in more efficient syntheses of complex anti-tumor natural products and analogs. In some cases, these new reactions constitute simple models of the enzymic processes which operate in biosynthetic pathways. The specific aims of this proposal concern substituent-directed oxidation reactions in which the attach of a metal oxide on an organic substrate such as an alkene is mediated by prior coordination of the oxidant with a ligand group present in the substrate, as is shown schematically below left. This methodology should result in greater selectivity and product control for allylic oxidations and oxidative cyclizations. This proposal contains two parts. The first part of the proposal describes a study of the mechanism and scope of these reactions. A series of model compounds will be prepared and subjected to various reaction conditions, and the composition of the products and the rate of reaction will be monitored by appropriate spectroscopic techniques. Correlations will be established between the selectivity observed, and the reaction conditions and substrate structure, with the goal of establishing a predictive rationale. The second part describes an approach to the total synthesis of the anti-tumor agent Chapliatrin using the new methodology in a key oxidative cyclization step.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
  • Funding Mechanism
  • Study Section
    MCHA
  • Study Section Name
    Medicinal Chemistry Study Section
  • Organization Name
    POLYTECHNIC UNIVERSITY
  • Organization Department
  • Organization DUNS
  • Organization City
    NEW YORK
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    11201
  • Organization District
    UNITED STATES